No CrossRef data available.
Published online by Cambridge University Press: 23 March 2020
Social cognition is impaired in patients with schizophrenia [1]. This impairment is one of the core features of the illness and has a clear impact on functional outcome.
While conventional antipsychotics might have a worsening effect on social cognition, e.g. on amygdala attenuation in fMRI studies on facial recognition [2], atypical antipsychotics might not show this effect [3].
Social cognitive training [4] – such as the training of affect recognition [5] – is a promising approach in the treatment of schizophrenia.
Holistic strategies including both treatment with atypical antipsychotics and social cognitive training can improve functional outcome in patients with schizophrenia [6].
The author has not supplied his declaration of competing interest.
Comments
No Comments have been published for this article.